Rockwell Medical Inc RMTI:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
1.21quote price arrow down-0.03 (-2.42%)
Volume
5,618
Close
1.24quote price arrow up+0.01 (+0.81%)
Volume
1,904,575
52 week range
0.83 - 3.85

...

Loading . . .

KEY STATS

  • Open1.26
  • Day High1.28
  • Day Low1.12
  • Prev Close1.23
  • 52 Week High3.85
  • 52 Week High Date03/06/20
  • 52 Week Low0.83
  • 52 Week Low Date11/02/20
  • Market Cap116.03M
  • Shares Out93.57M
  • 10 Day Average Volume1.54M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • 1 Year % Change-64.37

RATIOS/PROFITABILITY

  • EPS (TTM)-0.43
  • P/E (TTM)-2.86
  • Fwd P/E (NTM)-3.82
  • EBITDA (MRQ)-26.929M
  • ROE (MRQ)-89.78%
  • Revenue (MRQ)62.52M
  • Gross Margin (MRQ)5.52%
  • Net Margin (MRQ)-47.23%
  • Debt To Equity (MRQ)49.57%

EVENTS

  • Earnings Date03/14/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Rockwell Medical Inc News

There is no recent news for this security.

Latest RMTI News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Rockwell Medical, Inc. is a biopharmaceutical company. The Company is targeting end-stage renal disease and chronic kidney disease with products for the treatment of iron deficiency and hemodialysis. The Company is also a manufacturer of hemodialysis concentrates for dialysis providers and distributors. The Company’s renal drug therapy, Triferic, supports disease management initiatives. Triferic is therapy indicated to replace iron and maintain hemoglobin in hemodialysis...
John McLaughlin
Chairman
Russell Ellison M.D.
President
Russell Skibsted
Chief Financial Officer
Paul McGarry
Chief Accounting Officer
Address
30142 WIXOM ROAD
Wixom, MI
48393
United States